| Product Code: ETC7659971 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Precision Oncology Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Precision Oncology Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Precision Oncology Market - Industry Life Cycle |
3.4 Israel Precision Oncology Market - Porter's Five Forces |
3.5 Israel Precision Oncology Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Israel Precision Oncology Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Israel Precision Oncology Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Israel Precision Oncology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Israel |
4.2.2 Growing adoption of precision medicine in oncology |
4.2.3 Technological advancements in genomics and molecular diagnostics |
4.3 Market Restraints |
4.3.1 High costs associated with precision oncology treatments |
4.3.2 Limited reimbursement policies for precision oncology |
4.3.3 Stringent regulatory requirements for precision medicine |
5 Israel Precision Oncology Market Trends |
6 Israel Precision Oncology Market, By Types |
6.1 Israel Precision Oncology Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Precision Oncology Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Israel Precision Oncology Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.1.4 Israel Precision Oncology Market Revenues & Volume, By Therapeutics, 2021- 2031F |
6.2 Israel Precision Oncology Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Precision Oncology Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.3 Israel Precision Oncology Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.4 Israel Precision Oncology Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.2.5 Israel Precision Oncology Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.6 Israel Precision Oncology Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.7 Israel Precision Oncology Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Precision Oncology Market, By End-use |
6.3.1 Overview and Analysis |
6.3.2 Israel Precision Oncology Market Revenues & Volume, By Hospitals & Diagnostic Laboratories, 2021- 2031F |
6.3.3 Israel Precision Oncology Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.3.4 Israel Precision Oncology Market Revenues & Volume, By Healthcare Data Companies, 2021- 2031F |
7 Israel Precision Oncology Market Import-Export Trade Statistics |
7.1 Israel Precision Oncology Market Export to Major Countries |
7.2 Israel Precision Oncology Market Imports from Major Countries |
8 Israel Precision Oncology Market Key Performance Indicators |
8.1 Adoption rate of precision oncology treatments in Israel |
8.2 Number of precision oncology clinical trials conducted in the country |
8.3 Investment in research and development of precision oncology technologies |
9 Israel Precision Oncology Market - Opportunity Assessment |
9.1 Israel Precision Oncology Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Israel Precision Oncology Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 Israel Precision Oncology Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Israel Precision Oncology Market - Competitive Landscape |
10.1 Israel Precision Oncology Market Revenue Share, By Companies, 2024 |
10.2 Israel Precision Oncology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here